13F-HR filed by DAFNA Capital Management LLC
DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 88 holding rows worth $100,779,000.
- Accession
- 0001389933-15-000019
- Filer
- CIK 1389933
- Filed
- 2015-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2015
A holdings report, 88 entries on the cover page, a total value of $100,779,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $100,779,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFischel Nathan028-12328
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ATRICURE INC | 04963C209 | COM | 487,946 | $10,691,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 116,581 | $6,343,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 366,554 | $5,781,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 66,194 | $4,346,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 480,300 | $3,319,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 258,642 | $2,949,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 165,669 | $2,939,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 235,645 | $2,884,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 106,018 | $2,747,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,109,740 | $2,741,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 4,000,000 | $2,698,000 | thousands by filing date | principal |
| DISCOVERY LABORATORIES INC N | 254668403 | COM NEW | 7,508,544 | $2,253,000 | thousands by filing date | |
| INSULET CORP | 45784PAD3 | NOTE 2.000% 6/1 | 2,407,000 | $2,229,000 | thousands by filing date | principal |
| APPLIED GENETIC TECHNOL CORP | 03820J100 | COM | 157,192 | $2,066,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 111,466 | $1,985,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 46,010 | $1,774,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 356,918 | $1,681,000 | thousands by filing date | |
| XENOPORT INC | 98411C100 | COM | 470,612 | $1,633,000 | thousands by filing date | |
| SYNERGY PHARMACEUTICALS DEL | 871639308 | COM NEW | 296,563 | $1,572,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 228,500 | $1,424,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 1,193,189 | $1,408,000 | thousands by filing date | |
| CYTRX CORP | 232828509 | COM PAR $.001 | 583,013 | $1,382,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 93,574 | $1,337,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 63,400 | $1,332,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,372,862 | $1,274,000 | thousands by filing date | |
| CELYAD ONCOLOGY SA | 151205200 | ADR | 30,000 | $1,256,000 | thousands by filing date | |
| AVALANCHE BIOT | 05337G107 | Common Stock | 140,600 | $1,159,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 156,904 | $1,142,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 101,841 | $1,062,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 123,500 | $1,014,000 | thousands by filing date | |
| NUVASIVE INC | 670704AC9 | CORPORATE OBLIG | 760,000 | $959,000 | thousands by filing date | principal |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 53,241 | $942,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 79,812 | $941,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 68,900 | $930,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 9,400 | $877,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 70,885 | $780,000 | thousands by filing date | |
| INTEC PHARMA LTD JERUSALEM | M53644106 | SHS | 135,000 | $756,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 181,818 | $736,000 | thousands by filing date | |
| ARENA PHARMECEUTICALS INC | 040047102 | COMMON STOCK | 381,600 | $729,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 35,000 | $716,000 | thousands by filing date | |
| CYNAPSUS THERAPEUTICS INC | 23257Y859 | COM PAR NO PAR | 44,824 | $707,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 26,390 | $633,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 85,947 | $615,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 18,000 | $590,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 90,000 | $589,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 135,927 | $567,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 5,200 | $562,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 5,700 | $560,000 | thousands by filing date | |
| EXACTECH INC | 30064E109 | COM | 31,636 | $551,000 | thousands by filing date | |
| IRONWOOD PHARMA | 46333XAC2 | NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV | 600,000 | $537,000 | thousands by filing date | principal |
| CYNAPSUS THERAPEUTICS INC | 23257Y156 | COM | 33,995 | $536,000 | thousands by filing date | |
| LIPOCINE INC NEW | 53630X104 | CMN | 45,000 | $532,000 | thousands by filing date | |
| TARGACEPT INC | 87611RAA6 | NOTE 2/1 | 530,821 | $531,000 | thousands by filing date | principal |
| DERMIRA INC | 24983L104 | COM | 22,500 | $525,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 24,000 | $514,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 6,000 | $513,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 3,700 | $512,000 | thousands by filing date | |
| VTV THERAPEUTICS INC CL A | 918385105 | Stock | 75,000 | $489,000 | thousands by filing date | |
| COGENTIX MED INC COM | 19243A104 | Stock | 351,781 | $436,000 | thousands by filing date | |
| TOBIRA THERAPEUTICS INC COM | 88883P101 | COM | 45,092 | $436,000 | thousands by filing date | |
| LUMENIS LTD | M6778Q121 | SHS CL B | 31,072 | $430,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 2,430 | $403,000 | thousands by filing date | |
| CARDICA INC | 14141R101 | COM | 1,402,762 | $379,000 | thousands by filing date | |
| CATALYST | 14888D109 | COM | 70,903 | $330,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 36,551 | $322,000 | thousands by filing date | |
| CHECK CAP LTD | M2361E112 | SHS | 109,900 | $307,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 81,509 | $245,000 | thousands by filing date | |
| GENVEC INC NEW | 37246C307 | cs | 95,800 | $221,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 25,000 | $207,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 11,745 | $205,000 | thousands by filing date | |
| VENAXIS INC | 92262A107 | COM | 650,400 | $200,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 15,000 | $195,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 22,319 | $186,000 | thousands by filing date | |
| Sierra Oncology, Inc. | 74346L101 | common | 8,500 | $174,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS INC | 00507W107 | COM | 90,000 | $159,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 14,800 | $153,000 | thousands by filing date | |
| ENTEROMEDICS INC | 29365M208 | COM NEW | 500,000 | $130,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 86,768 | $108,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 36,180 | $99,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 21,722 | $88,000 | thousands by filing date | |
| CEL SCI CORP | 150837508 | COM PAR $0.01 | 139,500 | $84,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 19,239 | $83,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 50,000 | $79,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 45,000 | $77,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,709 | $70,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 5,000 | $51,000 | thousands by filing date | |
| GALMED PHARMACEUTICALS LTD | M47238106 | SHS | 5,871 | $44,000 | thousands by filing date | |
| CHECK CAP LTD | M2361E120 | *W EXP 02/28/202 | 55,000 | $28,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001389933-15-000019 | this filing | 2015-11-13 | acceptance time not in the bulk data set |